Team:Calgary Entrepreneurial/Project/Model

From 2013.igem.org

(Difference between revisions)
Line 28: Line 28:
<h2>Year One</h2>
<h2>Year One</h2>
-
<p>This will be a busy year seeing us continuing development of the technology.</p>
+
<p>We will find ourselves continuing the development of our technology and strategical protecting our positioning in the market through intellectual property.</p>
<p>Funding Source: Grants, Company, Private Investment</p>
<p>Funding Source: Grants, Company, Private Investment</p>
<p>Milestones: Prototype Development, Patent, Licensing Agreements/Partnerships, Regulatory Assessment</p>
<p>Milestones: Prototype Development, Patent, Licensing Agreements/Partnerships, Regulatory Assessment</p>

Revision as of 00:34, 25 October 2013

FREDsense's website works best with Javascript enabled, especially on mobile devices. Please enable Javascript for optimal viewing.

Milestones

Ensuring that we achieve success in a timely manner it is vital to the success of FREDsense. We have strategically planned our actions going forward to both utilize our resources in the most effective way and to meet the needs of our market. Here we outline how FREDsense will grow over the next 5 years.

Our Ongoing Plan

Pushing FREDsense forward relies on an aggressive set of key milestones that we will need to meet over the next 5 years. Meeting these challenges will help put FREDsense in a powerful position to solve problems and build better biosensors. These milestones are broken down into 1, 3, and 5 year goals.

Year One

We will find ourselves continuing the development of our technology and strategical protecting our positioning in the market through intellectual property.

Funding Source: Grants, Company, Private Investment

Milestones: Prototype Development, Patent, Licensing Agreements/Partnerships, Regulatory Assessment

Year Three

Funding Source: Angel Investment, Grants

Milestones: Prototype Validation, Manufacturing Contracts, Pre-sales, Product Demonstration, Regulatory Approval

Year Five

Funding Source: Venture Capital Funding

Milestones: Capture 30% of Market, Product Diversification, Expand to USA